(PQ5) Mitochondria in Leukemic Stem Cell Disease Progression
(PQ5) Mitochondria in Leukemic Stem Cell Disease Progression
批准号:
9172951
负责人:
SAGHI GHAFFARI
金额:
$38.66万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-09-01 至 2021-08-31
关键词:
AddressBloodBlood typing procedureCell MaintenanceDataDiseaseDisease ProgressionDoxycyclineDrug resistanceDysmyelopoietic SyndromesEpigenetic ProcessEventExhibitsFOXO3A geneFailureFlow CytometryGenerationsGeneticGoalsHealthHematologic NeoplasmsHematopoieticHematopoietic stem cellsHeterogeneityLabelLaboratoriesLeukemic CellLeukemic Hematopoietic Stem CellMaintenanceMatrix MetalloproteinasesMetabolicMetabolismMitochondriaModelingModificationMolecularMyeloproliferative diseasePathway interactionsPhenotypePlayPopulationProcessPropertyRegulationRelapseStem cellsTestingTransgenic Micebaseblood groupcancer stem cellconventional therapydesignimprovedleukemialeukemic stem cellmitochondrial metabolismmortalitymouse modelnovelpreventstemstem cell biologysuccesstargeted treatmenttherapy resistanttranscription factortranscriptome
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
Conventional and targeted therapies have had little success in eradicating myeloid malignancies
including in myeloproliferative neoplasms (MPNs). The inability to reliably prevent the generation of a small
subset of drug-resistant stem cell-like leukemic cells (or leukemic stem cells (LSCs)) that cause relapse and
the incapacity to target LSC has contributed to this failure. Mitochondrial metabolism has been implicated in
regulating both LSC and hematopoietic stem cells (HSC) activity, however many other aspects of
mitochondrial functions that contribute to the health of stem cell machinery remain largely unknown. We
have discovered mitochondrial heterogeneity in a highly purified population of primitive HSC. Overall our
results indicate that mitochondrial heterogeneity might subdivide stem cell compartment into fractions with
distinct properties and activities. In addition, we have shown that the transcription factor FOXO3 that is
required for both normal hematopoietic and leukemic stem cell maintenance is essential for HSC
mitochondrial metabolism. Based on our studies and the similarities of normal blood-forming and leukemic
stem cells, we propose to test the hypothesis that deregulated FOXO3 activity promotes the generation of
pre-leukemic stem cells in the context of myeloid malignancies. We propose to test this hypothesis in a
model of MPN that designate a group of blood clonal stem cell disorders that have the potential to progress
to leukemia and in which metabolic/mitochondrial pathways have been broadly implicated. We will take
advantage of mitochondrial heterogeneity to identify subpopulations of HSC and LSC with distinct stem cell
properties and potential. Aim 1: To investigate functional consequences of Long-term-HSC
mitochondrial heterogeneity; Aim 2: To elucidate the mechanism of FOXO3 regulation of
mitochondria in stem cells. These studies are highly likely to improve our understanding of leukemic stem
cell biology and the contribution of mitochondria to the LSC generation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Towards Understanding Molecular Mechanisms of Human Hematopoietic Stem Cells' Quiescence
-
批准号:10346063
-
项目类别:
-
资助金额:$33.8万
-
财政年份:2022
-
负责人:SAGHI GHAFFARI
-
依托单位:
Towards Understanding Molecular Mechanisms of Human Hematopoietic Stem Cells' Quiescence
-
批准号:10570203
-
项目类别:
-
资助金额:$33.8万
-
财政年份:2022
-
负责人:SAGHI GHAFFARI
-
依托单位:
FOXO3 Regulation of Normal and Stress Erythropoiesis
-
批准号:9264330
-
项目类别:
-
资助金额:$42.31万
-
财政年份:2017
-
负责人:SAGHI GHAFFARI
-
依托单位:
Mitochondria in the Regulation of Terminal Erythropoiesis
-
批准号:10587056
-
项目类别:
-
资助金额:$53.34万
-
财政年份:2017
-
负责人:SAGHI GHAFFARI
-
依托单位:
FOXO3 Regulation of Normal and Stress Erythropoiesis
-
批准号:9403199
-
项目类别:
-
资助金额:$42.31万
-
财政年份:2017
-
负责人:SAGHI GHAFFARI
-
依托单位:
(PQ5) Mitochondria in Leukemic Stem Cell Disease Progression
-
批准号:9336279
-
项目类别:
-
资助金额:$38.66万
-
财政年份:2016
-
负责人:SAGHI GHAFFARI
-
依托单位:
(PQ5) Mitochondria in Leukemic Stem Cell Disease Progression
-
批准号:9753161
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2016
-
负责人:SAGHI GHAFFARI
-
依托单位:
Lysosomes and their Communications with Mitochondria in Leukemic Stem Cell Disease Progression
-
批准号:10688239
-
项目类别:
-
资助金额:$39.33万
-
财政年份:2016
-
负责人:SAGHI GHAFFARI
-
依托单位:
Lysosomes and their Communications with Mitochondria in Leukemic Stem Cell Disease Progression
-
批准号:10522534
-
项目类别:
-
资助金额:$40.14万
-
财政年份:2016
-
负责人:SAGHI GHAFFARI
-
依托单位:
AKT Signaling and Oxidative Stress Regulation of Erythropoiesis
-
批准号:8470631
-
项目类别:
-
资助金额:$34.87万
-
财政年份:2009
-
负责人:SAGHI GHAFFARI
-
依托单位:
AKT Signaling and Oxidative Stress Regulation of Erythropoiesis
-
批准号:8288261
-
项目类别:
-
资助金额:$36.13万
-
财政年份:2009
-
负责人:SAGHI GHAFFARI
-
依托单位:
AKT Signaling and Oxidative Stress Regulation of Erythropoiesis
-
批准号:8098934
-
项目类别:
-
资助金额:$36.13万
-
财政年份:2009
-
负责人:SAGHI GHAFFARI
-
依托单位:
AKT Signaling and Oxidative Stress Regulation of Erythropoiesis
-
批准号:7656120
-
项目类别:
-
资助金额:$40.68万
-
财政年份:2009
-
负责人:SAGHI GHAFFARI
-
依托单位:
GROWTH, DIFFERENTIATION AND GENETIC ALTERATION OF HUMAN ES CELLS
-
批准号:7092817
-
项目类别:
-
资助金额:$5.56万
-
财政年份:2005
-
负责人:SAGHI GHAFFARI
-
依托单位:
Forkhead Transcription Factors in Stem Cell Development
-
批准号:6893338
-
项目类别:
-
资助金额:$17.5万
-
财政年份:2004
-
负责人:SAGHI GHAFFARI
-
依托单位:
Forkhead Transcription Factors in Stem Cell Development
-
批准号:6767036
-
项目类别:
-
资助金额:$17.5万
-
财政年份:2004
-
负责人:SAGHI GHAFFARI
-
依托单位:
IN VIVO SIGNALING OF THE ERYTHROPOIETIN RECEPTOR
-
批准号:2601257
-
项目类别:
-
资助金额:$8.16万
-
财政年份:1998
-
负责人:SAGHI GHAFFARI
-
依托单位:
IN VIVO SIGNALING OF THE ERYTHROPOIETIN RECEPTOR
-
批准号:2896461
-
项目类别:
-
资助金额:$8.21万
-
财政年份:1998
-
负责人:SAGHI GHAFFARI
-
依托单位:
IN VIVO SIGNALING OF THE ERYTHROPOIETIN RECEPTOR
-
批准号:6660665
-
项目类别:
-
资助金额:$4.49万
-
财政年份:1998
-
负责人:SAGHI GHAFFARI
-
依托单位:
IN VIVO SIGNALING OF THE ERYTHROPOIETIN RECEPTOR
-
批准号:6376734
-
项目类别:
-
资助金额:$9.29万
-
财政年份:1998
-
负责人:SAGHI GHAFFARI
-
依托单位:
海外基金